Narcan Naloxone Hci Spray
Product Images NDC 51662-1240

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Narcan Naloxone Hci (NDC 51662-1240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Serialized Label (1240 2 Serialized)

Packaging box of NARCAN NALOXONE HCI nasal spray, strength 4 mg/.1 mL. The white box features red asterisk-like symbols and text indicating it is a nasal spray. The labeler is HF Acquisition Co LLC, DBA HealthFirst. The box includes a barcode and NDC number 51662-1240.*

FDA Label Image

5166212401 Narcan Front

NARCAN Naloxone HCl nasal spray in a 4 mg/.1 mL dosage form is shown in sealed blister packaging. The product is labeled as a human prescription drug and distributed by HF Acquisition Co LLC, DBA HealthFirst. The visible part of the label includes a barcode and instruction to see the manufacturer's package insert.*

FDA Label Image

Clinical Pharma Image (Clinical Pharma Image)

Two graphs showing naloxone plasma concentration (ng/mL) over time (hours postdose) for various naloxone spray doses and intramuscular injection. The left graph presents data up to 6 hours postdose with multiple dosing regimens including 2 mg, 4 mg, and 8 mg sprays in different nostril configurations and a 0.4 mg IM injection. The right graph shows a detailed view of the first hour postdose for the same dosing regimens.*

FDA Label Image

Clinical Tabel (Clinical Pharmacology Table)

A data table comparing pharmacokinetic parameters of NARCAN NALOXONE HCI nasal spray at different doses and routes, including 2 mg one nasal spray, 4 mg two nasal sprays, 4 mg one nasal spray, 8 mg two nasal sprays, and 0.4 mg intramuscular injection. Parameters listed include tmax, Cmax, AUCt, AUC0-inf, t½, and dose normalized relative bioavailability versus intramuscular injection.*

FDA Label Image

Img 4 (Ifu Img 4 2)

An instructional illustration showing a hand holding a nasal spray device, spraying medication into a nostril. The image demonstrates the nasal administration route for dosing.*

FDA Label Image

Img 5 (Ifu Img 5)

An instructional illustration showing a person lying on their side in the recovery position. The diagram highlights that the hand supports the head and the knee stops the body from rolling onto the stomach.*

FDA Label Image

Img 1 (Ifu Img 1)

An instructional illustration showing hands opening or peeling back a product's information leaflet or insert. The image likely depicts the first step in accessing detailed drug information for NARCAN NALOXONE HCI nasal spray.*

FDA Label Image

Img 2 (Ifu Img 2)

Illustration showing a hand holding a nasal spray device. The diagram labels the nozzle and plunger components, indicating how to hold the spray for administration.*

FDA Label Image

Img 3 (Ifu Img 3)

An instructional illustration showing a person lying down with another person administering a nasal spray into one nostril, demonstrating the use of a nasal spray device. The illustration emphasizes proper positioning for nasal drug delivery.*

FDA Label Image

Narcon Spray (Narcon Spray 69547 353 02 Label)

The image shows a single-unit blister pack of NARCAN (naloxone HCl) Nasal Spray 4 mg. The white nasal spray device is visible within a clear plastic shell. The label on the foil backing next to the device includes storage instructions, dosage information stating each dose contains 4 mg naloxone HCl in 0.1 mL nasal spray, and usage directions for known or suspected opioid overdose. The product is marked Rx Only and includes a barcode and lot number with expiration date Apr 2018.*

FDA Label Image

Serialized 1240-1 (Serialized 1240 1)

Label of NARCAN Nasal Spray 4 mg spray for nasal use, prescription only. The label includes storage instructions, lot number, and expiration date. Distributed by HF Acquisition Co LLC and Adapt Pharma, Inc. A peel here indicator and a barcode are also visible on the label.*

FDA Label Image

Structure (Structure Description)

Chemical structure of naloxone hydrochloride (NARCAN NALOXONE HCI), showing the molecular framework including hydroxyl groups, nitrogen atoms, and associated hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.